SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001626199-21-000143
Filing Date
2021-11-10
Accepted
2021-11-10 16:19:37
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alpn-20210930.htm   iXBRL 10-Q 2000091
2 EX-31.1 alpn-ex311_20210930.htm EX-31.1 9055
3 EX-31.2 alpn-ex312_20210930.htm EX-31.2 9030
4 EX-32.1 alpn-ex321_20210930.htm EX-32.1 6177
5 EX-32.2 alpn-ex322_20210930.htm EX-32.2 6383
  Complete submission text file 0001626199-21-000143.txt   5938900

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20210930.xsd EX-101.SCH 32981
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alpn-20210930_cal.xml EX-101.CAL 54020
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alpn-20210930_def.xml EX-101.DEF 137877
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20210930_lab.xml EX-101.LAB 442614
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20210930_pre.xml EX-101.PRE 258039
11 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20210930_htm.xml XML 767138
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37449 | Film No.: 211396945
SIC: 2834 Pharmaceutical Preparations